Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban is indicated to delay imminent pre-term birth in pregnant adult women. Atosiban is useful in improving the pregnancy outcome of in vitro fertilization-embryo transfer (IVF-ET) in patients with repeated implantation failure (RIF). The pregnancy rate improved from zero to 43.7%.https://www.creative-peptides.com/product/atosiban-item-10-101-05-14.html
Answer: After mitosis, the daughter cell has 20 chromosomes and after meiosis, the daughter cell has 10 chromosomes.
Explanation:
